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culturesThis protocol describes the peptidomic analysis of organoid lysates, FACS-purified cell
populations, and 2D culture secretions by liquid chromatography mass spectrometry (LC-MS).
Currently, most peptides are quantified by ELISA, limiting the peptides that can be studied.
However, an LC-MS-based approach allows more peptides to be monitored. Our group has
previously used LC-MS for tissue peptidomics and secretion of enteroendocrine peptides from
primary culture. Now, we extend the use to organoid models.Miedzybrodzka et al., STAR
Protocols 1, 100164
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This protocol describes the peptidomic analysis of organoid lysates, FACS-puri-
fied cell populations, and 2D culture secretions by liquid chromatography mass
spectrometry (LC-MS). Currently, most peptides are quantified by ELISA, limiting
the peptides that can be studied. However, an LC-MS-based approach allows
more peptides to be monitored. Our group has previously used LC-MS for tissue
peptidomics and secretion of enteroendocrine peptides from primary culture.
Now, we extend the use to organoid models.
For complete details on the use and execution of this protocol, please refer to
Goldspink et al. (2020).BEFORE YOU BEGIN
Organoid Culture
Timing: 2–3 weeks
This protocol describes the processes and methods involved in the peptidomics analysis of
human intestinal organoids, which would be applicable to any organoid line that
synthesizes bioactive peptides. However, organoid culture protocols differ significantly
depending on the tissue, species, and cell types of interest. Organoids of interest should be
generated, cultured, and differentiated using existing protocols. For details of the generation,
culture, and genetic modification of human intestinal organoids, please refer to (Fujii et al.,
2015).
Note: The techniques we describe here use organoids grown in matrix domes of
Basement Membrane Extract (BME) or Matrigel in 6-well tissue culture plates. Depending
on the expression level of peptides of interest, one confluent well is typically enough
for peptide measurement of organoid lysates or collection of 2D secretion supernatants
from two stimulation conditions. The number of organoid wells required for fluores-
cence-activated cell sorting (FACS) must be empirically determined based on the cell
population(s) of interest; we recommend collecting >10,000 cells for each peptidomic
analysis.STAR Protocols 1, 100164, December 18, 2020 ª 2020 The Authors.











































ProtocolCRITICAL: All organoid culture should be carried out under aseptic conditions in a
biosafety hood.
CRITICAL: The use of human or animal tissue for research purposes is subject to ethical and
legislative restrictions, appropriate approvals must be obtained before commencing work.KEY RESOURCES TABLEAGENT or RESOURCE SOURCE IDENTIFIER
emicals, Peptides, and Recombinant Proteins
rskolin Sigma-Aldrich F6886
MX (3-isobutyl-1-methylxanthine) Sigma-Aldrich I7018
anidine Hydrochloride Fisher 364791000
etonitrile Sigma-Aldrich 1.00029.2500
-MS Grade Water Fisher M/0112/17
rmic Acid Fisher A117-50
ethanol Fisher M/4058/17
etic Acid Fisher 0714500ML
thiothreitol (DTT) Sigma-Aldrich 43819
doacetamide Sigma-Aldrich I1149
monium Bicarbonate Sigma-Aldrich 09830
vine serum albumin (BSA; 10%
lution in DPBS, low endotoxin,






vanced DMEM/F12 Invitrogen 12634010
sement Membrane Extract (BME)





Scientific Laboratory Supplies 11543550
ucose Sigma-Aldrich G7021
27632 dihydrochloride Tocris 1254/50
nk’s Balanced Salt Solution (HBSS) Sigma-Aldrich H9394
tal Bovine Serum (FBS) Gibco 10270-106
ypLE Express Gibco 12605036
ll Recovery Solution Corning 354253
posited Data
rted cell peptidomics data PRIDE repository https://www.
ebi.ac.uk/pride/
PXD017825
perimental Models: Cell Lines
LU-Venus ileal organoid line (Goldspink et al., 2020) N/A
ftware and Algorithms
FACSChorus BD Biosciences N/A
AKS (v8.5) Bioinformatics Solutions Inc http://www.bioinfor.com/
peaks-studio/
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER




Oasis HLB Prime mElution Solid
Phase Extraction (SPE) Plate
Waters 186008052
CellTrics 50 mm disposable filters Sysmex 04-0042-2317
SPE manifold Waters 186006961
SPE Dry 96 system Biotage SD-9600-DHS-EU
Quanrecovery Extraction Plates Waters 186009184
UltiMate 3000 nano LC Thermo Fisher Scientific ULTIM3000RSLCNANO
Q Exactive Plus Orbitrap mass spectrometer Thermo Fisher Scientific IQLAAEGAAPFALGMBDK
Protein LoBind Eppendorf tubes (1.5 mL) Thermo Fisher Scientific 10708704
Nano LC trap cartridge Thermo Fisher Scientific 160454
Easy-Spray nano LC column (250 3
0.075 mm)
Thermo Fisher Scientific ES802A
5 mL Round-Bottom Polypropylene tubes Corning 352063
ll
OPEN ACCESSProtocolMATERIALS AND EQUIPMENTSaline Buffer Preparation
Reagent Final Concentration (mM) Amount
KCl 4.5 0.3354 g
NaCl 138 8.065 g
NaHCO3 4.2 0.3528 g
NaH2PO4 1.2 0.144 g
CaCl2 (1M) 2.6 2.6 mL
MgCl2 (1M) 1.2 1.2 mL
HEPES 10 2.383 g
NaOH (1M) Adjust to pH 7.4 ~5 mL
ddH2O n/a To 1,000 mL
Total n/a 1000 mLNote: Saline buffer can be stored at 2C–8C for up to 6 months after preparation. 0.001% (w/
v) fatty acid-free BSA and glucose (typically 10 mM) are added on day of use.FACS Media
Reagent Final Concentration Amount
HBSS 90% 45 mL
FBS 10% 5 mL
Y-27632 (10 mM stock) 10 mM 50 mL
Total n/a 50 mLNote: FACS media (without Y-27632) can be stored at 4C for up to 1 month. Y-27632 should
be added on day of use.STAR Protocols 1, 100164, December 18, 2020 3
6 M Guanidine Hydrochloride
Reagent Final Concentration (mM) Amount
Guanidine hydrochloride 6000 5.73 g
LC-MS grade water n/a To 10 mL
Total 6000 10 mL
ll
OPEN ACCESS ProtocolNote: 6 M guanidine hydrochloride can be stored at 22C for up to 3 months after
preparation.50 mM Ammonium Bicarbonate
Reagent Final Concentration (mM) Amount
Ammonium bicarbonate 50 1.97 g
LC-MS grade water n/a 500 mL
Total 50 500 mLNote: 50 mM ammonium bicarbonate (aq) can be stored at 22C for up to 3 months after
preparation.10 mM DTT in 50 mM Ammonium Bicarbonate
Reagent Final Concentration (mM) Amount
DTT 10 0.0154 g
Ammonium bicarbonate (50 mM) 50 10 mL
Total n/a 10 mLNote: This solution is prepared fresh immediately before use.100 mM Iodoacetamide in 50 mM Ammonium Bicarbonate
Reagent Final Concentration (mM) Amount
Iodoacetamide 100 0.1849 g
Ammonium bicarbonate (50 mM) 50 10 mL
Total n/a 10 mLNote: This solution is prepared fresh immediately before use.LC-MS System Setup
 Samples are loaded onto a 0.3 3 5 mm peptide trap column (Thermo Fisher Scientific) at a flow
rate of 30 mL/min and analyzed using a 2503 0.075 mm Easy-Spray column (Thermo Fisher Scien-
tific). Both nano and trap column temperatures are set at 45C during the analysis.
 The mobile phases are A: 0.1% formic acid in water (v/v) and B: 0.1% formic acid (v/v) in 80:20 ace-
tonitrile:water (LC-MS grade). Chromatographic conditions are initially 2.5% B, held for 15 min,
followed by an increase to 50% B over 90 min, the column is then washed with 90% B for
20 min before returning to starting conditions for a further 20 min, totaling an entire run time of
130 min at a flow rate of 300 nL/min (Table 1).
CRITICAL: Safety precautions must be taken, and appropriate PPE (i.e., laboratory coat,
goggles and gloves) worn when preparing LC solvents. Acetonitrile is harmful if in contact4 STAR Protocols 1, 100164, December 18, 2020
Table 1. Liquid Chromatography Gradient Parameters










OPEN ACCESSProtocolwith skin. Formic acid is highly corrosive to eyes, skin, and the respiratory system and
should therefore always be added in a fume hood.
 Eluted peptides are directly introduced into themass spectrometer by positive nano electro-spray
ionization using a spray voltage of 1.8 kV, and an S-lens setting of 70 V.
 The mass spectrometer is set to perform full MS scans at 1 microscan with a resolution of 70,000,
over a mass range of 400–1,600m/z. Following each survey scan, the top 10 ions of each spectrum
are selected for MS/MS analysis, and ions selected for fragmentation are added to an exclusion list




Default charge state 4
Mass analyzer Orbitrap
Orbitrap resolution 70,000
Scan range (m/z) 400–1,600
Automatic Gain Control (AGC) target 3e6
Micro scans 1
Number of dependent scans 10 (from most intense precursors)
Resolution 17,500
Maximum fill time 300 ms
Mass range fixed lower m/z = 100
AGC target 1e5
Microscans 1
Normalized collision energy (%) 24, 28
Charge exclusion exclude unassigned and +1 charge state
Dynamic exclusion 60 s Data are acquired with Xcalibur software version v4.3.73.11.
Alternatives: This protocol is illustrative of our specific LC-MS/MS approach using a Thermo
Fisher Scientific Ultimate 3000 nano LC system coupled to a Q Exactive Plus Orbitrap mass
spectrometer. However, alternative LC-MS systems with similar capabilities (nanoflow, mass




ProtocolCRITICAL: The instrument should be regularly calibrated, and performance validated with
frequent in-house quality controls prior to any sample analysis. See Troubleshooting 1.STEP-BY-STEP METHOD DETAILS
Recovery and Lysis of Organoids
Timing: 1 h
These steps describe the recovery of organoids frommatrix domes and subsequent lysis in 6 M gua-
nidine hydrochloride.
1. Recover organoids from matrix domes.
a. Aspirate organoid culture media.
b. Add 2 mL of ice-cold Cell Recovery Solution (Corning) per 6-well.
c. Use a P1000 micropipette to scrape and collect organoids into LoBind 1.5 mL Eppendorf
tubes.
d. Incubate on ice for 30–60 min, inverting halfway through to mix organoids, to allow matrix to
dissolve.
e. Centrifuge at 600 3 g for 5 min to pellet organoids.
f. Discard supernatant (including any matrix on top of the pellet).
2. Wash organoids with ice-cold PBS.
a. Add 1 mL ice-cold PBS to each tube.
b. Gently rotate and invert tube to resuspend organoid pellet.
c. Centrifuge at 600 3 g for 5 min to pellet organoids.
d. Discard supernatant (including any matrix on top of the pellet).
e. Repeat steps a-d until no visible matrix remains.
Note: Using ice-cold Cell Recovery Solution and PBS aids with the removal of organoids from
extracellular matrix (of the BME domes) and also reduces peptide degradation.
CRITICAL: Avoid touching organoids while removing supernatant as they will readily stick
to pipette tips. BSA should not be added above 0.001% to prevent sticking as this will
interfere with the LC-MS analysis.
CRITICAL: Remainingmatrix may interfere with peptide extraction and LC-MS. Organoids
should be washed with ice-cold PBS until no visible matrix remains (normally 2–3 times).
3. Add 25 mL of 6 M guanidine hydrochloride per organoid dome to resuspend pellet (typically 300–
500 mL is used per confluent 6-well) and snap freeze on dry ice.
Pause Point: Samples can be frozen at70C until ready to continue with peptide extractionPeptide Extraction of Lysed Organoids
Timing: 21 h
This method describes peptide extraction of whole lysed organoid cultures.
4. Defrost the samples on ice and precipitate with a 1:5 ratio of 80% acetonitrile (ACN) in water.
a. If necessary, transfer samples to a larger Eppendorf tube prior to precipitation.STAR Protocols 1, 100164, December 18, 2020
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OPEN ACCESSProtocolNote: Precipitation will result in the formation of three layers within the sample; organic,
aqueous, and solid cell precipitate. Centrifugation and placing the sample on ice will clarify
the layers, see step 5.
5. Centrifuge at 3,5003 g for 5 min at 4C and transfer the aqueous phase (lower), without disturb-
ing the precipitate, to a clean LoBind Eppendorf tube.
6. Evaporate the supernatant in a rotary evaporator until dry (usually takes ~18 h; overnight evap-
oration).
7. Reconstitute in 250 mL 0.1% formic acid in water (v/v) and transfer onto an Oasis HLB Prime mE-
lution solid phase extraction (SPE) plate (Waters) and gently apply positive pressure on an SPE
manifold.
8. Wash all samples with the following reagents, ensuring the SPE plate reservoirs are clear before
each step.a. 200 mL 0.1% formic acid in water (v/v).
b. 200 mL 5% methanol:1% acetic acid in water (v/v).9. Elute the samples into a clean QuanRecovery plate with two 30 mL aliquots of 60% meth-
anol:10% acetic acid in water (v/v).
10. Evaporate the supernatant, under nitrogen at 40C on a Biotage SPE Dry 96 system until dry.
11. Reconstitute into 75 mL 10 mM DTT in 50 mM ammonium bicarbonate.
12. Incubate the samples for 1 h at 60C.
13. Add 20 mL 100 mM iodoacetamide in 50 mM ammonium bicarbonate.
14. Incubate for 30 min at 18C–25C, in the dark.
15. Dilute the samples with 25 mL 1% formic acid in water (v/v).
Note: Reduction and alkylation (steps 11–14) breaks disulfide-bonded peptides so they can
be identified in the bioinformatics analysis. These steps can be removed but this will reduce
the number of positive peptide matches. If a targeted quantitation approach is being used,
the SPE extract is to be diluted with 75 mL 0.1 % formic acid in water (v/v) after step 9 for
LC-MS/MS analysis.Purification of Cell Populations by FACS
Timing: 3–4 h
This method describes the isolation of cell populations by FACS based on the presence of fluores-
cent reporters.
16. Recover organoids from matrix domes.a. Aspirate organoid culture media.
b. Add 2 mL of ice-cold Advanced DMEM/F12 (ADF) per 6-well.
c. Use a P1000 micropipette to scrape and collect organoids into 15 mL centrifuge tube(s).
d. Centrifuge at 400 3 g for 5 min to pellet organoids.
e. Discard supernatant.17. Digest organoids to single cells.a. Resuspend pellet in 5 mL of TrypLE Express per 6-well.
b. Incubate in a water bath at 37⁰C for 20 min.
c. Mechanically triturate organoids 10–20 times each with P1000 and P200 micropipettes.
d. Take a small drop (~20 mL) of the cell suspension onto a Petri dish and check under a micro-
scope for the presence of single cells.
e. Repeat steps b-d, checking digestion at 5–20 min intervals, until a largely single-cell suspen-
sion is obtained.STAR Protocols 1, 100164, December 18, 2020 7
Figure 1. Successful and Unsuccessful 2D Organoid Cultures
2D organoid-derived cultures observed following overnight incubation and thorough washing with saline buffer. Scale bar, 200 mm. Successful cultures
can be high (A) or low (B) density. Unsuccessful cultures can adhere as single cells (C) or fail to flatten (D).
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OPEN ACCESS ProtocolNote: Digestion to single cells typically requires 30–60 min incubation with TrypLE at 37⁰C,
depending on organoid size and morphology. To enhance digestion, organoids can be trans-
ferred to a 50 mL tube during step 17 (which prevents organoids settling to the bottom of the
tube) but should be returned to 15 mL tubes for centrifugation. Some small clusters of up to
ten cells are acceptable at this stage as they will be further broken up by mechanical
trituration.
18. Wash organoids with FACS media.8
a. Centrifuge at 400 3 g for 5 min to pellet single cells.
b. Discard supernatant.
c. Mechanically triturate organoids 10–20 times each with P200 and P20 micropipettes.
d. Resuspend pellet in 5 mL of FACS media.
e. Repeat steps a-d two more times, then pass cell suspension though a 50 mm cell strainer.19. Repeat steps 18a–c and resuspend in FACS media supplemented with live cell dyes (for
example, 5 mM DRAQ5 and/or 2 mg/mL DAPI).
20. Transfer single-cell suspension to 5 mL round bottomed polypropylene FACS tubes.
21. Sort cell populations of interest directly into 350 mL of 6 M guanidine hydrochloride in LoBind
1.5 mL Eppendorf tubes.
Note:Where possible we recommend collecting >10,000 cells per population for peptidomic
analysis, although we have previously measured high-abundance peptides from as few as 100
cells from fresh tissue. Follow manufacturer instructions regarding use of cell sorters. See
Figure 1 for an example FACS sort layout.STAR Protocols 1, 100164, December 18, 2020
Figure 2. Sample FACS Layout
Representative sort layout from 500k events, showing data from human ileal organoids expressing Venus under
control of the proglucagon promoter (GLU-Venus) (Goldspink et al, 2020). Single cells were selected based on their
side scatter (SSC) and forward scatter (FSC) (top row) and live single cells were further isolated from dead cells and
debris based on DAPI and DRAQ5 fluorescence as indicated, before Venus-fluorescence positive (+ve) cells were
distinguished from non-fluorescent negative (-ve) cells (bottom row).
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OPEN ACCESSProtocol22. Vortex briefly and then immediately snap freeze cells on dry ice after sorting.
Pause Point: Samples can be frozen at70C until ready to continue with peptide extraction
Note: As there is 10% FBS present in the FACS media, some bovine derived peptides will be
carried through to LC-MS analysis. The impact on peptidomics is minimal, however for prote-
omic analysis the bovine peptides will generate interferences to the database search. If inter-
ested in proteomics analysis, use 0.1% BSA or a lower concentration of FBS in FACS media.Extraction of FAC-Sorted Cells
Timing: 21 h
23. Thaw sorted cell samples on ice and then re-freeze on dry ice (or in a70C freezer) followed by
defrosting on ice.
24. Add 900 mL of 80% ACN in water to each sample and vortex mix.
25. Centrifuge at 12,000 3 g for 5 min at 4C and transfer the aqueous phase (lower) to a clean Lo-
Bind Eppendorf.
26. Evaporate the supernatant in a rotary evaporator until dry (usually takes ~18 h; overnight evap-
oration).
27. Reconstitute in 500 mL 0.1% formic acid in water (v/v).
28. Transfer samples onto an Oasis HLB Prime mElution solid phase extraction (SPE) plate (Waters)
and gently apply positive pressure on an SPE manifold.STAR Protocols 1, 100164, December 18, 2020 9
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OPEN ACCESS Protocol29. Wash all samples with the following reagents, ensuring the SPE plate reservoirs are clear before
each step.10a. 200 mL 0.1% formic acid in water (v/v).
b. 200 mL 5% methanol:1% acetic acid in water (v/v).30. Elute the samples into a clean Quanrecovery plate with two 30 mL aliquots of 60%methanol:10%
acetic acid in water (v/v).
31. Evaporate the supernatant under nitrogen at 40C on a Biotage SPE Dry 96 system until dry.
32. Reconstitute into 75 mL of 10 mM DTT in 50 mM ammonium bicarbonate.
33. Incubate the samples for 1 h at 60C.
34. Add 20 mL 100 mM iodoacetamide in 50 mM ammonium bicarbonate.
35. Incubate for 30 min at 18C–25C, in the dark.
36. Dilute the samples with 25 mL 1% formic acid in water (v/v).Generation of 2D Organoid Cultures
Timing: 20 h
This method describes the preparation of 2D organoid cultures for secretion experiments. The num-
ber of organoids required will depend on expression levels of the peptides of interest and differen-
tiation conditions. To assess gut hormone secretion from intestinal organoid cultures (as described
in Goldspink et al., 2020), we recommend that one confluent well of a 6-well plate is used to seed six
wells of a 24-well plate.
37. Pre-coat plates with Matrigel.a. Thaw Matrigel aliquot on ice.
b. Prepare an appropriate volume of 2% v/v Matrigel in ice-cold ADF.
c. Add 300 mL of 2% Matrigel to the required number of wells of a 24-well plate.
d. Incubate Matrigel-coated places at 37C for approximately 1 h.
38. Meanwhile, recover organoids from matrix domes.a. Aspirate organoid culture media.
b. Add 2 mL of ice-cold Advanced DMEM/F12 (ADF) per 6-well.
c. Use a P1000 micropipette to scrape and collect organoids into a 15 mL centrifuge tube.
d. Centrifuge at 500 3 g for 5 min to pellet organoids then discard supernatant.39. Resuspend organoid pellet in 4 mL of TrypLE Express per 6-well.a. Incubate in a water bath for 8–12 min at 37C.
b. Centrifuge at 400 3 g for 5 min to pellet organoids then discard supernatant.
c. Triturate 10–20 times with a P200 micropipette to mechanically disrupt the organoid pellet.
Note: For optimal attachment, aim for small clusters of 10–20 cells (this can be visualized after
plating or by directly observing cells in a 15 mL tube at any point under a light microscope).
40. Resuspend pellet in organoid culture media + 10 mM Y-27632 (250 mL/24-well, pre-warmed to
37C) to obtain a cell suspension.
41. Aspirate Matrigel solution from pre-coated plate.a. Immediately add pre-warmed organoid culture media + 10 mM Y-27632 (250 mL/24-well) to
each well.42. Plate 250 mL of the cell suspension per well.
Note: To ensure consistency between wells, mix the cell suspension by pipetting regularly
during plating to ensure the suspension remains homogenous. After plating, gently shake
plates (left to right and back to front) to ensure cells do not clump in the center of the well.STAR Protocols 1, 100164, December 18, 2020
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OPEN ACCESSProtocol43. Incubate overnight (18–24 h) in an incubator (37C, 5% CO2) to allow cell adhesion before stim-
ulating secretion.Collection of 2D Secretion Supernatants
Timing: 2 h
This method describes the collection of supernatants from 2D organoid cultures stimulated under
different conditions. This is performed in 24-well plates and it may be necessary to combine super-
natants collected from multiple wells, depending on the peptides of interest and LC-MS sensitivity.
To measure ileal gut hormone secretion (as described in Goldspink et al., 2020), we combine super-
natants from three wells of a 24-well plate. Strong stimulants – such as forskolin/IBMX (each 10 mM)
which elevate intracellular cAMP levels – can be used to assess secretion of peptides from a range of
cell types. Alternatively, drugs which target specific receptors or molecular pathways can be tested
to determine whether these stimulate or inhibit secretion of peptides of interest.
44. Following overnight incubation, observe cultures under a light microscope (Figure 2)
Note: See Expected Outcomes and Troubleshooting 2
45. Add 0.001% fatty acid-free BSA and, if required, glucose (normally 10 mM) to an appropriate
volume of saline buffer and pre-warm to 37C (this solution is termed secretion buffer).
46. Wash cultures with pre-warmed secretion buffer.a. Aspirate overnight culture media.
b. Add approximately 300 mL of warm secretion buffer to each well to wash cultures.
c. Aspirate secretion buffer.
d. Repeat steps b-c twice more then add a further 300 mL of warm secretion buffer to each well
and incubate at 37C for 30 min (meanwhile proceed to step 47).
Note: These wash steps should not be too gentle as they aim to remove unattached cells or
debris and wash off all culture media (which may interfere with LC-MS). The 30 min pre-incu-
bation step allows acclimatization of cells to the low-nutrient secretion buffer.
47. Prepare stimulant solutions in secretion buffer (200 mL is required per well of a 24-well plate, and
should be made up with 10% excess volume) and keep at 37C.
48. After the 30 min pre-incubation, remove all the secretion buffer from wells (using a P1000 micro-
pipette with the plate tilted to a 45 angle) and add 200 mL of stimulant solution to each well.
Note: To avoid cells drying out, buffer should only be removed from 3–4 wells at a time
49. Incubate with stimulants at 37C for 1 h.
a. Meanwhile label and pre-chill (on ice) two LoBind 1.5 mL Eppendorf tubes per condition.50. Collect supernatants into pre-chilled LoBind 1.5 mL Eppendorf tubes.
Note: Supernatants from multiple wells can be combined at this step, if required for peptide
detection by LC-MS. Steps 50–52 should be performed on ice using pre-chilled tubes to mini-
mize peptide degradation
51. Centrifuge at 2,000 3 g for 5 min at 4C to pellet any debris or detached cells.
52. Transfer 180 mL (or greater volume if multiple wells were combined in step 50) of each superna-
tant to fresh LoBind tubes, taking care to avoid touching any pellet which forms.STAR Protocols 1, 100164, December 18, 2020 11
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OPEN ACCESS ProtocolCRITICAL: As intracellular levels of secreted peptides are normally higher than in super-
natants, any detached cells will interfere with quantification
53. Immediately snap freeze on dry ice.
Pause Point: Samples can be frozen at 70C until continuing with peptide extractionExtraction of Secretion Samples
Timing: 1 h
This method describes the extraction of peptides from organoid secretion supernatants.
54. Thaw secretion samples, if frozen, on ice.
55. To each sample, add 50 mL of 1% formic acid in water (v/v) and gently mix.
CRITICAL: Ensure steps 54 and 55 are performed on wet ice
Note: If performing targeted quantitation of peptides prepare an internal standard solution in
1% formic acid in water (v/v) and add 50 mL instead of blank solvent
56. Transfer samples onto an Oasis HLB Prime mElution solid phase extraction (SPE) plate (Waters)
and gently apply positive pressure on an SPE manifold.
57. Wash all samples with the following reagents, ensuring the SPE plate wells are clear before each
step:12a. 200 mL 0.1% formic acid in water (v/v)
b. 200 mL 5% methanol:1% acetic acid in water (v/v)58. Elute the samples into a clean Quanrecovery plate with two 30 mL aliquots of 60%methanol:10%
acetic acid in water (v/v).
59. Dilute the samples with 75 mL 0.1% formic acid in water (v/v).Analysis of Peptides by Liquid Chromatography Mass Spectrometry
Timing: 130 min per sample
This step describes sample data acquisition of extracted samples by LC-MS analysis. Extracts are
analyzed using a Thermo Fisher Scientific Ultimate 3000 nano LC system coupled to a Q Exactive
Plus Orbitrap mass spectrometer according to the analytical parameters stated previously in LC-
MS system set up.
60. Prior to injection onto the liquid chromatography (LC) system, centrifuge samples at 3,500 3 g
for 10 min.
61. Inject samples onto LC-MS system for analysis; recommended volumes of 30 mL for secretion
supernatants and lysed organoids, and 40 mL for sorted cells.
Note: See Troubleshooting 3 if chromatography is not as expectedQuantification of Peptides in Raw LC-MS Data Files Using Qual Browser and Quan Browser
Software
Timing: up to 4 h depending on the number of LC-MS data files being searchedSTAR Protocols 1, 100164, December 18, 2020
Figure 3. Peptides Matched against Proglucagon Sequence and Example GLP-17-37 Chromatogram
Results from a sample from Goldspink et al. (2020).
(A) A PEAKS output showing the assignment of matched peptides against the proglucagon sequence from a lysed organoid sample.
(B) Extracted ion chromatogram ofm/z values relating to the [M + 4H]4+ charge state of the GLP-1 7-37 peptide generates a peak that can be integrated
to semi-quantitatively monitor the peptide.
(C) Ions relating to the [M + 4H]4+ charge state of the GLP-I 7-37 peptide.
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OPEN ACCESSProtocol62. Using PEAKS software (v8.5), open a representative LC-MS file in Qual Browser that will contain
peptides of interest.
63. Extract them/z ion specific for the peptide (as specified in the PEAKS software viewer) using the
ranges function on the chromatogram pane (Figure 3B).
64. Sum spectra under the peak at the expected retention time as specified in the PEAKS software
(Figure 3C).
65. Note the m/z values of the peptide 13C isotopes for the peptide, usually the top 4 ions will suf-
fice. Adding ions of low abundance can sometimes have little impact on signal, but can increase
chromatogram noise.STAR Protocols 1, 100164, December 18, 2020 13
Figure 4. Procedure for Generating a Processing Method
(A) Selection of LC-MS data function.
(B) Selection of full scan data filter.
(C) Enable mass range selection.
(D) Input of specific m/z values for peptide of interest, a G tolerance of 0.01 m/z is achieved by specifying 10 mmu in the ‘‘masses’’ function under the
options tab (I), as well as the decimal place selection (J).
(E) Expected peptide retention time.
(F) Peptide selection time window tolerance.
(G) Chromatogram view window range.
(H) Integration algorithm selection.
(K) Detection tab inset, showing selection of seven smoothing points (helps obtain more consistent peak integration).
(L) Chromatogram showing peak integration using the selected m/z values and integration parameters.
(M) Spectrum of peptide under integrated peak.
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OPEN ACCESS Protocol66. Open Processing Setup program from the Xcalibur launch page.
67. Input peptide name, select MS full scan filter scan filter,m/z values retention time and chromato-
gram window settings as specified in Figure 4.
68. Open file list containing all LC-MS files and select batch reanalysis function to perform quanti-
tative analysis of the data using the specified processing method.
69. Check integration of peptide peaks are correct, and if needed make changes to integration
manually, or update the automatic integration parameters to reprocess all the integrations for
a specific peptide (Figure 5).EXPECTED OUTCOMES
Each sample injected onto the LC-MS system will generate a Total Ion Chromatogram (TIC) which is
made up of all ionized species and can be filtered by mass ranges to identify the presence of specific
peptide fragments. The data for each sample are processed using PEAKS software (v8.5) which
matches experimentally acquired MS/MS spectra against proteins in the UniProt database (Figure
3A). Exporting data from the PEAKS software generates relative quantitative data at the protein level
such that comparison between samples can be performed in other statistical software packages,
such as RStudio.14 STAR Protocols 1, 100164, December 18, 2020
Figure 5. Procedure for Performing the Quantitative Analysis of Raw LC-MS Data Files
(A) Peptide peak areas in analyzed samples.
(B) Integration of peptide, which can be manually changed if needed.
(C) User integration parameters can be modified and applied to all to improve automatic peptide integration.
(D) Selection of specific peptide from list of target peptides.
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OPEN ACCESSProtocolSee Figure 3 for an example of a peptide m/z isotope pattern and the identification of the specific
retention time for peptide peak area integration purposes. This approach allows for the generation
of semi-quantitative measurements of peptides – or fully quantitative if peptide standards are co-ex-
tracted and analyzed.QUANTIFICATION AND STATISTICAL ANALYSIS
To compare the levels of specific peptides, it is recommended that the raw data are interro-
gated manually. Each peptide generates a signature pattern in the MS data, and will acquire
a varied number of charges to generate predictable mass to charge ratio (m/z) values. Close
interrogation of each charge state will show that peptides will regularly have multiple 13C iso-
topes, therefore it is important to identify these and include them in the quantitative analysis
to improve sensitivity.
Software packages that are supplied with the instrument, such as Qual Browser (Supplied in Xca-
libur), can be used to interrogate the raw data to identify the specific m/z values for targeted
peptide quantitation. Once the specific m/z patterns for each target peptide are identified, these
can be used to quantify multiple peptides using other software packages, such as Quan Browser
(Supplied in Xcalibur). Once the retention time of the peptide and the m/z values are identified,
then the peak integration can be optimized for each peptide to ensure reproducibility in peak
area assignment. Figures 4 and 5 shows an example of sample quantitation from Goldspink
et al. (2020).
Peak area values can then be compared between samples in statistical software, such as RStudio.STAR Protocols 1, 100164, December 18, 2020 15
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Due to the chemical properties of peptides, not all peptides are extracted equally by this method
and the extraction recovery and sensitivity of the LC-MS approach may vary for different peptides.
Nanoflow liquid chromatography runs take approximately 2 h to perform. This makes the method
low throughput and therefore not suitable for large sample sets. The approach is also relatively
expensive and requires the use of high cost and complex instrumentation.
The full scan peptidomic method described generates significant amounts of data (approximately 1
GB per 2 h analysis), which can be time consuming to process. Additionally, this type of measure-
ment will identify all ionized species in the samples which may include unwanted contaminants,
such as BSA, media components, and peptides from typical cell turnover processes. These may
compete for MS/MS fragmentation selection with peptides of interest, which will reduce the depth
of peptide identification in samples. If data are only required on known peptides, a more targeted
analysis using a triple quadrupole MS system can be used instead of a high-resolution mass spec-
trometer. These systems are specifically designed to be used for quantitative peptidomics analysis
and are usually employed in a higher throughput manner compared to traditional discovery pepti-
domics methods.TROUBLESHOOTING
Problem 1
Poor LC-MS chromatographical peak shape and sensitivity (step 61).Potential Solution
Over time, the efficiency of LC-MS consumables (columns and traps) can decline, this leads to poor
chromatographic separation, shifts in retention time, and broadening of peptides which results in a
reduction in the sensitivity of the LC-MS.
Regular checks on the suitability of the LC-MS system should be performed by analyzing a standard
peptide solution and monitoring the peak retention times and signal of key peptides. Trap column
cartridges can be replaced quickly, while new analytical columns require more effort to get running
again.
Over time the MS instrument might accumulate dirt on the orifice, reducing sensitivity which will
require the transfer tube to be removed and cleaned.Problem 2
Poor formation of 2D cultures (step 43).Potential Solution
When plating 2D cultures, organoids should be broken up into small clusters of 10–20 cells. If orga-
noids are not sufficiently broken up, then 3D structures may reform during overnight incubation. By
contrast, if organoids are broken down too harshly, they form sparse or single-cell cultures. Ensure Y-
27632 is added to culture media during plating to limit anoikis-induced cell death. Plating density
must be optimized based on organoid size and number of organoids per well. Some differentia-
tion-promoting compounds (such as Notch inhibitors) may also interfere with cellular attachment.
Cultures should be plated on a thin coat of Matrigel (2%) to improve attachment. Increasing the Ma-
trigel pre-coating period from 1 h to up to 8 hmay improve poor cellular attachment. See Figure 2for
a comparison of successful and unsuccessful organoid cultures.Problem 3
Expected peptides not detected by LC-MS (step 61).16 STAR Protocols 1, 100164, December 18, 2020
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This could be caused by poorly differentiated organoids lacking mature cell types. Organoid culture
protocols should be optimized prior to peptidomic analyses using techniques such as qPCR, immu-
nostaining, and the presence of fluorescent reporters. Methods used for culture of human small in-
testinal organoids are described in Goldspink et al, 2020.
LC-MS analyses are generally less sensitive than antibody-based methods and therefore a large
number of organoids are normally required for sample extraction, depending on the expression
levels of the peptides of interest. We recommend analyzing organoid lysates by LC-MS/MS to
make sure they are producing the peptide of interest before attempting experiments using sorted
cells or secretion supernatants. Detection of gut hormone peptides can be improved by using cul-
ture protocols which selectively drive the enteroendocrine lineage (Beumer et al., 2020, Goldspink
et al., 2020).
In some instances, peptides may not be found during database searches which can be caused by
peptide degradation. The presence of breakdown products can be used to confirm if this has
occurred during sample extraction. The use of short incubation periods and performing sample
collection on ice is more effective at preventing over-fragmentation than the addition of protease
inhibiting peptides. The addition of formic acid immediately prior to extraction after thawing will
help reduce proteolytic activity, while the addition of 6 M GuHCl to the homogenate analysis will
also prevent degradation during extraction.
RESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to and will be ful-
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Materials Availability
No new materials were generated in this study.
Data and Code Availability
The sorted cell peptidomics data have been deposited to the ProteomeXchange Consortium via the
PRIDE partner repository (PXD017825).
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